Gastroenterology in developing countries: Issues and advances

World Journal of Gastroenterology

Volumn 15, Issue 23, 2009, Pages 2839-2854

  Mandeville, Kate L ^a   Krabshuis, Justus ^b   Ladep, Nimzing Gwamzhi ^c   Mulder, Chris J J ^d   Quigley, Eamonn M M ^e   Khan, Shahid A ^f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Highland Data   (France)

^c UNIVERSITY OF JOS   (Nigeria)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY COLLEGE CORK   (Ireland)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Developing countries; Gastrointestinal diseases; Health care delivery; Helicobacter pylori; Practice guidelines

Indexed keywords

ANTIBIOTIC AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; ROTAVIRUS VACCINE; ZINC;

BACTERIAL TRANSMISSION; DEVELOPING COUNTRY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG COST; ENDOSCOPY; GASTROENTEROLOGY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HELICOBACTER INFECTION; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; ORAL REHYDRATION THERAPY; PERSONNEL SHORTAGE; PRACTICE GUIDELINE; PREVALENCE; REINFECTION; REVIEW; STAFF TRAINING; VIRUS INFECTION; WORK ENVIRONMENT;

EID: 67651251010     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2839     Document Type: Review

References (187)

1. Ferreira FH, Ravallion M. Global Poverty and Inequality: A review of the evidence. Policy research working paper for the World Bank. Washington: World Bank, 2008
2. World Health Organization. World Health Organization Statistical Information System (WHOSIS). Accessed August 4, 2008. Available from: URL: http://www.who.int/whosis/en/
3. International Monetary Fund Statistical Database. Accessed August 5, 2008. Available from: URL: http://www.imfstatistics.org/imf/
4. World Health Organization (WHO). World Health Report 2000 - Health systems: improving performance. Geneva: WHO, 2000. Available from: URL: http://www.who.int/whr/2000/en/
5. Snyder JD, Merson MH. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ 1982; 60: 605-613
6. World Health Organization (WHO). World Health Statistics 2008. Geneva: WHO, 2008. Available from: URL: http://www.who.int/whosis/ whostat/2008/en/index.html
7. Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000; 14: 65-69
8. Huilan S, Zhen LG, Mathan MM, Mathew MM, Olarte J, Espejo R, Khin Maung U, Ghafoor MA, Khan MA, Sami Z. Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 1991; 69: 549-555
9. Levine MM. Enteric infections and the vaccines to counter them: future directions. Vaccine 2006; 24: 3865-3873
10. World Health Organization. Persistent diarrhoea in children: CCD/ DDM/85.1. Diarrhoeal disease control. Geneva: World Health Organization, 1985
11. Bairagi R, Chowdhury MK, Kim YJ, Curlin GT, Gray RH. The association between malnutrition and diarrhoea in rural Bangladesh. Int J Epidemiol 1987; 16: 477-481
12. Mittal SK. Chronic diarrhea in tropics. Indian J Pediatr 1999; 66: S4-S15
13. Moore SR, Lima AA, Conaway MR, Schorling JB, Soares AM, Guerrant RL. Early childhood diarrhoea and helminthiases associate with long-term linear growth faltering. Int J Epidemiol 2001; 30: 1457-1464
14. Checkley W, Buckley G, Gilman RH, Assis AM, Guerrant RL, Morris SS, Mølbak K, Valentiner-Branth P, Lanata CF, Black RE. Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol 2008; 37: 816-830
15. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999; 61: 707-713
16. Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, Guerrant RL. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg 2002; 66: 590-593
17. Fisher RB, Parsons DS. Glucose movements across the wall of the rat small intestine. J Physiol 1953; 119: 210-223
18. Riklis E, Quastel JH. Effects of cations on sugar absorption by isolated surviving guinea pig intestine. Can J Biochem Physiol 1958; 36: 347-362
19. Crane RK. Hypothesis for mechanism of intestinal active transport of sugars. Fed Proc 1962; 21: 891-895
20. Guerrant RL, Carneiro-Filho BA, Dillingham RA. Cholera, diarrhea, and oral rehydration therapy: triumph and indictment. Clin Infect Dis 2003; 37: 398-405
21. ICDDR, B and ORS: the history of a miracle discovery. Glimpse 1994; 16: 3-4
22. Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000; 78: 1246-1255
23. Podewils LJ, Mintz ED, Nataro JP, Parashar UD. Acute, infectious diarrhea among children in developing countries. Semin Pediatr Infect Dis 2004; 15: 155-168
24. Lima AA, Soares AM, Freire Júnior JE, Guerrant RL. Cotransport of sodium with glutamine, alanine and glucose in the isolated rabbit ileal mucosa. Braz J Med Biol Res 1992; 25: 637-640
25. Silva AC, Santos-Neto MS, Soares AM, Fonteles MC, Guerrant RL, Lima AA. Efficacy of a glutamine-based oral rehydration solution on the electrolyte and water absorption in a rabbit model of secretory diarrhea induced by cholera toxin. J Pediatr Gastroenterol Nutr 1998; 26: 513-519
26. Abely M, Dallet P, Boisset M, Desjeux JF. Effect of cholera toxin on glutamine metabolism and transport in rabbit ileum. Am J Physiol Gastrointest Liver Physiol 2000; 278: G789-G796
27. Rhoads JM, Keku EO, Quinn J, Woosely J, Lecce JG. L-glutamine stimulates jejunal sodium and chloride absorption in pig rotavirus enteritis. Gastroenterology 1991; 100: 683-691
28. Bhan MK, Mahalanabis D, Fontaine O, Pierce NF. Clinical trials of improved oral rehydration salt formulations: a review. Bull World Health Organ 1994; 72: 945-955
29. Chowdhury AM, Karim F, Rohde JE, Ahmed J, Abed FH. Oral rehydration therapy: a community trial comparing the acceptability of homemade sucrose and cereal-based solutions. Bull World Health Organ 1991; 69: 229-234
30. World Health Organization. The treatment of diarrhoea: A manual for physicians and other senior health workers. Geneva: World Health Organization, 2005. Available from: URL: http://whqlibdoc.who.int/ publications/2005/9241593180.pdf
31. Murphy C, Hahn S, Volmink J. Reduced osmolarity oral rehydration solution for treating cholera. Cochrane Database Syst Rev 2004; CD003754
32. Banwell JG. Worldwide impact of oral rehydration therapy. Clin Ther 1990; 12 Suppl A: 29-36; discussion 36-37
33. Sarkar K, Sircar BK, Roy S, Deb BC, Biswas AB, Biswas R. Global review on ORT (oral rehydration therapy) programme with special reference to Indian scene. Indian J Public Health 1990; 34: 48-53
34. Nyatoti V, Nyati Z, Mtero S. Knowledge, attitudes and practices of mothers and health workers in relation to the use of sugar and salt solution in Masvingo Province, Zimbabwe. Cent Afr J Med 1993; 39: 95-102
35. Widarsa KT, Muninjaya AA. Factors associated with the use of oral rehydration solution among mothers in west Lombok, Indonesia. J Diarrhoeal Dis Res 1994; 12: 261-264
36. Rao KV, Mishra VK, Retherford RD. Mass media can help improve treatment of childhood diarrhoea. Natl Fam Health Surv Bull 1998; 1-4
37. Gupta DN, SenGupta PG, Sircar BK, Mondal S, Sarkar S, Deb BC. Implementation of ORT: some problems encountered in training of health workers during an operational research programme. Indian J Public Health 1994; 38: 69-72
38. Koul PB, Murali MV, Gupta P, Sharma PP. Evaluation of social marketing of oral rehydration therapy. Indian Pediatr 1991; 28: 1013-1016
39. Chowdhury AM, Karim F, Sarkar SK, Cash RA, Bhuiya A. The status of ORT (oral rehydration therapy) in Bangladesh: how widely is it used? Health Policy Plan 1997; 12: 58-66
40. Nations MK, de Sousa MA, Correia LL, da Silva DM. Brazilian popular healers as effective promoters of oral rehydration therapy (ORT) and related child survival strategies. Bull Pan Am Health Organ 1988; 22: 335-354
41. Bahl R, Bhandari N, Hambidge KM, Bhan MK. Plasma zinc as a predictor of diarrheal and respiratory morbidity in children in an urban slum setting. Am J Clin Nutr 1998; 68: 414S-417S
42. Naveh Y, Lightman A, Zinder O. Effect of diarrhea on serum zinc concentrations in infants and children. J Pediatr 1982; 101: 730-732
43. Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008; 121: 326-336
44. Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner JM, Hidayat A, Khatun F, Martorell R, Ninh NX, Penny ME, Rosado JL, Roy SK, Ruel M, Sazawal S, Shankar A. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000; 72: 1516-1522
45. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A, Khatun F, Martorell R, Ninh NX, Penny ME, Rosado JL, Roy SK, Ruel M, Sazawal S, Shankar A. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999; 135: 689-697
46. Brooks WA, Yunus M, Santosham M, Wahed MA, Nahar K, Yeasmin S, Black RE. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet 2004; 363: 1683-1688
47. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9: 565-572
48. Dennehy PH. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008; 21: 198-208
49. Fischer TK, Viboud C, Parashar U, Malek M, Steiner C, Glass R, Simonsen L. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007; 195: 1117-1125
50. Ling-Qiao Z. A rotavirus vaccine licensed in China. Health News 2001; 31: 1
51. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 1996; 97: 7-13
52. Santosham M, Moulton LH, Reid R, Croll J, Weatherholt R, Ward R, Forro J, Zito E, Mack M, Brenneman G, Davidson BL. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 1997; 131: 632-638
53. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350: 1205-1209
54. Pérez-Schael I, Guntiñas MJ, Pérez M, Pagone V, Rojas AM, González R, Cunto W, Hoshino Y, Kapikian AZ. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997; 337: 1181-1187
55. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48: 1-20
56. Centers for Disease Control and Prevention (CDC). Intussusception among recipients of rotavirus vaccine - United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48: 577-581
57. Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 2002; 110: e67
58. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33
59. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22
60. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79: 255-263
61. World Health Organization. Hepatitis B. Fact Sheet 204. Accessed August 4, 2008. Available from: URL: http://www.who.int/mediacentre/ factsheets/fs204/en/index.html
62. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16
63. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-2100
64. World Health Organization. World Health Report 1996: Fighting disease, fostering development. Geneva: World Health Organization, 1996. Available from: URL: http://www.who.int/whr/1996/en/index.html
65. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125
66. Beutels P. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). Health Econ 2001; 10: 751-774
67. Mast E, Mahoney F, Kane M, Margolis H. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: Saunders, 2004: 299-337
68. Whittle HC, Bradley AK, McLauchlan K, Ajdukiewicz AB, Howard CR, Zuckerman AJ, McGregor IA. Hepatitis B virus infection in two Gambian villages. Lancet 1983; 1: 1203-1206
69. Chen DS, Sung JL, Lai MY. A seroepidemiologic study of hepatitis B virus infection in Taiwan. Taiwan Yixuehui Zazhi 1978; 77: 908-918
70. Sung JL. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol Jpn 1984; 19: 363-366
71. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94-98
72. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 992-1000
73. McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603
74. Francis DP, Favero MS, Maynard JE. Transmission of hepatitis B virus. Semin Liver Dis 1981; 1: 27-32
75. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15: 7-16
76. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003; 289: 959-962
77. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13 Suppl 1: S47-S49
78. André FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990; 8 Suppl: S74-S78; discussion S79-S80
79. Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Longterm follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994; 140: 734-746
80. Expanded programme on immunization. Global Advisory Group - Part I. Wkly Epidemiol Rec 1992; 67: 11-15
81. World Health Organization. 2004 global immunization data. Geneva: World Health Organization, 2005. Available from: URL: http://www.who.int/ immunization_monitoring/data/GlobalImmunizationData.pdf
82. World Health Organization. Immunization surveillance, assessment and monitoring. Accessed July 28, 2008. Available from: URL: http://www.who.int/immunization_monitoring/data/en/
83. English P. Should universal hepatitis B immunisation be introduced in the UK? Arch Dis Child 2006; 91: 286-289
84. Aggarwal R, Ghoshal UC, Naik SR. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol 2003; 38: 215-222
85. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005; 194: 163-168
86. Bah E, Parkin DM, Hall AJ, Jack AD, Whittle H. Cancer in the Gambia: 1988-97. Br J Cancer 2001; 84: 1207-1214
87. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 1999; 17: 2946-2950
88. Chotard J, Inskip HM, Hall AJ, Loik F, Mendy M, Whittle H, George MO, Lowe Y. The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis 1992; 166: 764-768
89. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, George MO, Whittle HC. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 1993; 341: 1129-1131
90. Kane MA. Status of hepatitis B immunization programmes in 1998. Vaccine 1998; 16 Suppl: S104-S108
91. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28: 126-135
92. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982; 146: 198-204
93. Chan CY, Lee SD, Lo KJ. Legend of hepatitis B vaccination: the Taiwan experience. J Gastroenterol Hepatol 2004; 19: 121-126
94. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135: 796-800
95. Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001; 139: 349-352
96. Centers for Disease Control and Prevention (CDC). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 868-870
97. Martin JF, Marshall J. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund. Vaccine 2003; 21: 587-592
98. Global Alliance for Vaccines and Immunization. Performance. Accessed August 5, 2008. Available from: URL: http://www.gavialliance.org/performance
99. Torres J, Pérez-Pérez G, Goodman KJ, Atherton JC, Gold BD, Harris PR, la Garza AM, Guarner J, Muñoz O. A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch Med Res 2000; 31: 431-469
100. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186
101. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-565
102. Blaser MJ. The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 Suppl 1: 27-30
103. Graham DY. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma. Prev Med 1994; 23: 712-716
104. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543
105. World Gastroenterology Organisation. Practice guidelines: Helicobacter pylori in developing countries. 2006. Available from: URL: http://www.worldgastroenterology.org/ helicobacter-pylori-in-developing-countries.html
106. Lindkvist P, Enquselassie F, Asrat D, Muhe L, Nilsson I, Giesecke J. Risk factors for infection with Helicobacter pylori - a study of children in rural Ethiopia. Scand J Infect Dis 1998; 30: 371-376
107. Dominici P, Bellentani S, Di Biase AR, Saccoccio G, Le Rose A, Masutti F, Viola L, Balli F, Tiribelli C, Grilli R, Fusillo M, Grossi E. Familial clustering of Helicobacter pylori infection: population based study. BMJ 1999; 319: 537-540
108. Nabwera HM, Nguyen-Van-Tam JS, Logan RF, Logan RP. Prevalence of Helicobacter pylori infection in Kenyan schoolchildren aged 3-15 years and risk factors for infection. Eur J Gastroenterol Hepatol 2000; 12: 483-487
109. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, Forman D. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994; 308: 750-753
110. Malaty HM, Paykov V, Bykova O, Ross A, Graham DP, Anneger JF, Graham DY. Helicobacter pylori and socioeconomic factors in Russia. Helicobacter 1996; 1: 82-87
111. Torres J, Leal-Herrera Y, Perez-Perez G, Gomez A, Camorlinga-Ponce M, Cedillo-Rivera R, Tapia-Conyer R, Muñoz O. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 1998; 178: 1089-1094
112. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993; 34: 1672-1676
113. Malaty HM, Evans DG, Evans DJ Jr, Graham DY. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992; 103: 813-816
114. Frenck RW Jr, Clemens J. Helicobacter in the developing world. Microbes Infect 2003; 5: 705-713
115. Thomas JE, Dale A, Harding M, Coward WA, Cole TJ, Weaver LT. Helicobacter pylori colonization in early life. Pediatr Res 1999; 45: 218-223
116. Kindermann A, Demmelmair H, Koletzko B, Krauss-Etschmann S, Wiebecke B, Koletzko S. Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr 2000; 30: 85-91
117. Rehnberg-Laiho L, Rautelin H, Valle M, Kosunen TU. Persisting Helicobacter antibodies in Finnish children and adolescents between two and twenty years of age. Pediatr Infect Dis J 1998; 17: 796-799
118. Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ 1994; 309: 1119-1123
119. Rothenbacher D, Bode G, Berg G, Gommel R, Gonser T, Adler G, Brenner H. Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. Int J Epidemiol 1998; 27: 135-141
120. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes Infect 2003; 5: 693-703
121. Perri F, Pastore M, Leandro G, Clemente R, Ghoos Y, Peeters M, Annese V, Quitadamo M, Latiano A, Rutgeerts P, Andriulli A. Helicobacter pylori infection and growth delay in older children. Arch Dis Child 1997; 77: 46-49
122. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000; 22: 283-297
123. Clemens J, Albert MJ, Rao M, Huda S, Qadri F, Van Loon FP, Pradhan B, Naficy A, Banik A. Sociodemographic, hygienic and nutritional correlates of Helicobacter pylori infection of young Bangladeshi children. Pediatr Infect Dis J 1996; 15: 1113-1118
124. Mégraud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995; 9 Suppl 2: 85-91
125. Klein PD, Graham DY, Gaillour A, Opekun AR, Smith EO. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet 1991; 337: 1503-1506
126. Glynn MK, Friedman CR, Gold BD, Khanna B, Hutwagner L, Iihoshi N, Revollo C, Quick R. Seroincidence of Helicobacter pylori infection in a cohort of rural Bolivian children: acquisition and analysis of possible risk factors. Clin Infect Dis 2002; 35: 1059-1065
127. Rohr MR, Castro R, Morais M, Brant CQ, Castelo Filho A, Ferrari Júnior AP. Risk of Helicobacter pylori transmission by upper gastrointestinal endoscopy. Am J Infect Control 1998; 26: 12-15
128. Katoh M, Saito D, Noda T, Yoshida S, Oguro Y, Yazaki Y, Sugimura T, Terada M. Helicobacter pylori may be transmitted through gastrofiberscope even after manual Hyamine washing. Jpn J Cancer Res 1993; 84: 117-119
129. Langenberg W, Rauws EA, Oudbier JH, Tytgat GN. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis 1990; 161: 507-511
130. Tytgat GN. Endoscopic transmission of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9 Suppl 2: 105-110
131. Burstein M, Monge E, León-Barúa R, Lozano R, Berendson R, Gilman RH, Legua H, Rodriguez C. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol 1991; 13: 154-156
132. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. In: IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61. Lyon: International Agency for Research on Cancer, 1994: 177-241
133. McColl KE. What remaining questions regarding Helicobacter pylori and associated diseases should be addressed by future research? View from Europe. Gastroenterology 1997; 113: S158-S162
134. Kuipers EJ, Meijer GA. Helicobacter pylori gastritis in Africa. Eur J Gastroenterol Hepatol 2000; 12: 601-603
135. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol 2005; 40: 523-529
136. McColl KE, el-Omar E, Gillen D. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull 1998; 54: 121-138
137. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24
138. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Shimosegawa T, Toyota T. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000; 46: 20-26
139. Gilman RH, Partanen R, Brown KH, Spira WM, Khanam S, Greenberg B, Bloom SR, Ali A. Decreased gastric acid secretion and bacterial colonization of the stomach in severely malnourished Bangladeshi children. Gastroenterology 1988; 94: 1308-1314
140. Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut 1987; 28: 96-107
141. Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics 2007; 119: e754-e759
142. Sullivan PB, Thomas JE, Wight DG, Neale G, Eastham EJ, Corrah T, Lloyd-Evans N, Greenwood BM. Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child 1990; 65: 189-191
143. Passaro DJ, Taylor DN, Meza R, Cabrera L, Gilman RH, Parsonnet J. Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. Pediatrics 2001; 108: E87
144. Bravo LE, Mera R, Reina JC, Pradilla A, Alzate A, Fontham E, Correa P. Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J Pediatr Gastroenterol Nutr 2003; 37: 614-619
145. Demir H, Saltik IN, Kocak N, Yuce A, Ozen H, Gurakan F. Subnormal growth in children with Helicobacter pylori infection. Arch Dis Child 2001; 84: 89-90
146. Taşar A, Kibrisli E, Dallar Y. Seroprevalence of Helicobacter pylori in children with constitutional height retardation. Turk J Gastroenterol 2006; 17: 7-12
147. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781
148. Chinese Society of Gastroenterology, Chinese Medical Association. Consensus on the management of Helicobacter pylori infection: Tongcheng, Anhui Province, 2003. Chin J Dig Dis 2004; 5: 186-188
149. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12
150. Kawakami E, Ogata SK, Portorreal AC, Magni AM, Pardo ML, Patrício FR. Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents. Arq Gastroenterol 2001; 38: 203-206
151. Ford A, Moayyedi P. How can the current strategies for Helicobacter pylori eradication therapy be improved? Can J Gastroenterol 2003; 17 Suppl B: 36B-40B
152. Rollan A, Giancaspero R, Fuster F, Acevedo C, Figueroa C, Hola K, Schulz M, Duarte I. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000; 95: 50-56
153. Hildebrand P, Bardhan P, Rossi L, Parvin S, Rahman A, Arefin MS, Hasan M, Ahmad MM, Glatz-Krieger K, Terracciano L, Bauerfeind P, Beglinger C, Gyr N, Khan AK. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001; 121: 792-798
154. Rupnow MF, Shachter RD, Owens DK, Parsonnet J. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Vaccine 2001; 20: 879-885
155. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007; 12: 89-102
156. World Health Organization (WHO). World Health Report 2006: working together for health. Geneva: WHO, 2006. Available from: URL: http://www.who.int/whr/2006/whr06_en.pdf
157. Task Force for Scaling Up Education and Training for Health Workers, Global Health Workforce Alliance. Scaling up, saving lives. Geneva: Global Health Workforce Alliance, 2008. Available from: URL: http://www.who.int/workforcealliance/documents/ Global_Health%20SUMMARY.pdf
158. Hongoro C, McPake B. How to bridge the gap in human resources for health. Lancet 2004; 364: 1451-1456
159. Ministry of Health - Republic of Malawi. Human Resources in the Health Sector: Towards a Solution. Lilongwe: Ministry of Health, 2004
160. Record R, Mohiddin A. An economic perspective on Malawi's medical "brain drain". Global Health 2006; 2: 12
161. Mills EJ, Schabas WA, Volmink J, Walker R, Ford N, Katabira E, Anema A, Joffres M, Cahn P, Montaner J. Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? Lancet 2008; 371: 685-688
162. Martineau T, Decker K, Bundred P. "Brain drain" of health professionals: from rhetoric to responsible action. Health Policy 2004; 70: 1-10
163. Organization for Economic Cooperation and Development (OECD). Immigrant health workers in OECD countries in the broader context of highly skilled migration, Part III of International Migration Outlook 2007. Paris: OECD, 2007
164. Crisp N, Gawanas B, Sharp I. Training the health workforce: scaling up, saving lives. Lancet 2008; 371: 689-691
165. Narasimhan V, Brown H, Pablos-Mendez A, Adams O, Dussault G, Elzinga G, Nordstrom A, Habte D, Jacobs M, Solimano G, Sewankambo N, Wibulpolprasert S, Evans T, Chen L. Responding to the global human resources crisis. Lancet 2004; 363: 1469-1472
166. World Health Organization (WHO). World Health Report 2004: changing history. Geneva: WHO, cited 2008-07-22; 170. Available from: URL: http://www.who.int/whr/2004/en/report04_en.pdf
167. Awases M, Gbary A, Nyoni J, Chatora R. Migration of health professionals in six countries: A synthesis report. Brazzaville: World Health Organization Regional Office for Africa, 2004
168. Department of Health (England). Review body on doctors and dentists remuneration: Review for 2008. London: Department of Health, 2007
169. Hussain Z, Quigley EMM. Gastrointestinal issues in the assessment and management of the obese patient. Gastroenterol Hepatol 2007; 3: 559-569
170. Oxford Policy Management. External evaluation of the National Programme for Family Planning and Primary Health Care. Islamabad: Lady Health Worker Programme, 2002
171. Mkandawire N, Ngulube C, Lavy C. Orthopaedic clinical officer program in Malawi: a model for providing orthopaedic care. Clin Orthop Relat Res 2008; 466: 2385-2391
172. Conway M, Gupta S, Khajavi K. Addressing Africa's health workforce crisis. The McKinsey Quarterly. 2007. Available from: URL: http://www.mckinseyquarterly.com
173. Robinson M, Clark P. Forging solutions to health worker migration. Lancet 2008; 371: 691-693
174. Modernising Medical Careers (MMC) England. Recruitment to
175. Ladep NG, Sule J, Umar SM, Obienu O, Anyanechi C, Okeke EN. Oesophageal variceal band ligation using a saeed six-shooter multiband ligator; experience at Jos University Teaching Hospital, Nigeria: case report. Niger J Med 2008; 17: 110-111
176. Fried M, Farthing M, Krabshuis J, Quigley E. Global guidelines: is gastroenterology leading the way? Lancet 2006; 368: 2041-2042
177. Fried M, Quigley EM, Hunt RH, Guyatt G, Anderson BO, Bjorkman DJ, Farthing MJ, Fedail SS, Green-Thompson R, Hampton J, Krabshuis J, Laine L, Horton R. Are global guidelines desirable, feasible and necessary? Nat Clin Pract Gastroenterol Hepatol 2008; 5: 2-3
178. Fried M, Quigley EM, Hunt RH, Guyatt G, Anderson BO, Bjorkman DJ, Farthing MJ, Fedail SS, Green-Thompson R, Hampton J, Krabshuis J, Laine L, Horton R. Can global guidelines change health policy? Nat Clin Pract Gastroenterol Hepatol 2008; 5: 120-121
179. Fried M, Quigley EM, Hunt RH, Guyatt G, Anderson BO, Bjorkman DJ, Farthing MJ, Fedail SS, Green-Thompson R, Hampton J, Krabshuis J, Laine L, Horton R. Is an evidence-based approach to creating guidelines always the right one? Nat Clin Pract Gastroenterol Hepatol 2008; 5: 60-61
180. Fried M, Krabshuis J. Can 'Cascades' make guidelines global? J Eval Clin Pract 2008; 14: 874-879
181. World Gastroenterology Organisation (WGO). Practice guidelines: Acute diarrhoea. Munich: WGO, 2008: 28. Available from: URL: http://www.worldgastroenterology.org/acute-diarrhoea-in-adults.html
182. World Gastroenterology Organisation (WGO). Practice guidelines: Colorectal cancer screening. Paris: WGO, 2007: 18. Available from: URL: http://www.worldgastroenterology.org/colorectal-cancer-screening.html
183. World Gastroenterology Organisation (WGO). Practice guideline: Esophageal varices. Munich: WGO, 2008: 17. Available from: URL: http://www.worldgastroenterology.org/treatment-of-esophageal-varices.html
184. World Gastroenterology Organisation (WGO). Practice guideline: Hepatitis B. Munich: WGO, 2008. Available from: URL: http://www.worldgastroenterology.org/hepatitis-b.html
185. Anderson BO, Carlson RW. Guidelines for improving breast health care in limited resource countries: the Breast Health Global Initiative. J Natl Compr Canc Netw 2007; 5: 349-356
186. Yip CH, Anderson BO. The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther 2007; 7: 1095-1104
187. Sachs JD. Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. Geneva: World Health Organization, 2001